Agentic AI in Pharma: Merck & Google Cloud $1B Partnership
Merck's $1 billion partnership with Google Cloud aims to deploy agentic AI to transform drug discovery and boost productivity across its global enterprise.
- Publisher
- IntuitionLabs
- Published
- Length
- 17 pages
- File
- 517 KB PDF
Download the full 17-page PDF
Free · 517 KB · Instant access after email
This whitepaper analyzes the landmark partnership between Merck & Co. and Google Cloud, focusing on the deployment of agentic AI in the pharmaceutical sector.
- Merck commits up to $1 billion to enhance its digital backbone with Google Cloud's AI technologies.
- The partnership aims to digitize data and improve productivity for Merck's 75,000 employees.
- Agentic AI will enable autonomous agents to execute complex tasks with minimal human oversight.
- Key goals include accelerating drug discovery and optimizing clinical trial design.
- The collaboration reflects a broader trend of pharma companies leveraging AI for operational efficiency.
Ready to read the full report?
Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.
More whitepapers like this
Strategies to Enhance Recruitment of Female Participants to Cardiovascular Research
This consensus document outlines strategies to increase female representation in cardiovascular clinical trials, addressing significant under-representation of women.
British Society of Gastroenterology Guidelines on Inflammatory Bowel Disease in Adults: 2025
The updated BSG guidelines emphasize the necessity of ileocolonoscopy for IBD diagnosis and advocate for immunomodulators in all patients.
🔒 Agentic AI for Pharma Launches: Access & Engagement
Agentic AI can enhance pharma launches by improving market access and HCP engagement, with potential efficiency gains of up to 80%.